AI-designed molecule BRP suppresses appetite in animal tests

· Science · United States

Stanford researchers have identified a natural molecule, found with the help of AI, that sharply suppresses appetite and promotes fat loss in animals. Named BRP, the molecule reduced food intake by up to the level reported in the study's animals. The compound is being framed as a potential Ozempic-like weight-loss treatment without the common digestive side effects or significant muscle loss associated with existing GLP-1 drugs. The findings come from animal experiments and would still need clinical testing before any therapeutic use. The result adds to a fast-growing pipeline of obesity candidates, where drugmakers are racing to find alternatives to injectable GLP-1 therapies that offer better tolerability and preserve lean mass.

Why it matters：Obesity drug development is one of the largest commercial races in biopharma; a naturally derived, AI-discovered molecule with a different side-effect profile would intensify competition around next-generation weight-loss treatments.

Key points

  • The molecule was identified with AI assistance.
  • It reduced food intake in animals and promoted fat loss.
  • Researchers say it avoided digestive side effects and significant muscle loss seen with existing drugs.

Sources (original reporting)

More stories from this day